Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.

Article  PubMed  PubMed Central  Google Scholar 

Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249–56.

Article  PubMed  PubMed Central  Google Scholar 

Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547–58.

Article  PubMed  PubMed Central  Google Scholar 

Kirk B, Cawthon PM, Arai H, Ávila-Funes JA, Barazzoni R, Bhasin S, et al. The conceptual definition of sarcopenia: Delphi consensus from the Global Leadership Initiative in Sarcopenia (GLIS). Age Ageing. 2024. https://doi.org/10.1093/ageing/afae052.

Article  PubMed  PubMed Central  Google Scholar 

Bhasin S, Travison TG, Manini TM, Patel S, Pencina KM, Fielding RA, et al. Sarcopenia definition: the position statements of the Sarcopenia Definition and Outcomes Consortium. J Am Geriatr Soc. 2020;68(7):1410–8.

Article  PubMed  PubMed Central  Google Scholar 

Goates S, Du K, Arensberg MB, Gaillard T, Guralnik J, Pereira SL. Economic impact of hospitalizations in US adults with sarcopenia. J Frailty Aging. 2019;8(2):93–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Achison M, Adamson S, Akpan A, Aspray T, Avenell A, Band MM, et al. Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial. J Cachexia Sarcopenia Muscle. 2022;13(2):858–71.

Article  PubMed  PubMed Central  Google Scholar 

Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2019;21(3):300-7.e2.

Article  CAS  Google Scholar 

Rolland Y, Dray C, Vellas B, Barreto PS. Current and investigational medications for the treatment of sarcopenia. Metabolism. 2023;149:155597.

Article  CAS  PubMed  Google Scholar 

Dismore L, Hurst C, Sayer AA, Stevenson E, Aspray T, Granic A. Study of the older adults’ motivators and barriers engaging in a nutrition and resistance exercise intervention for sarcopenia: an embedded qualitative project in the MIlkMAN pilot study. Gerontol Geriatr Med. 2020;6:2333721420920398.

Article  PubMed  PubMed Central  Google Scholar 

Quan Y, Wang C, Wang L, Li G. Geriatric sarcopenia is associated with hypertension: a systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2023;25(9):808–16.

Article  PubMed  PubMed Central  Google Scholar 

Gao K, Cao LF, Ma WZ, Gao YJ, Luo MS, Zhu J, et al. Association between sarcopenia and cardiovascular disease among middle-aged and older adults: findings from the China health and retirement longitudinal study. EClinicalMedicine. 2022;44:101264.

Article  PubMed  PubMed Central  Google Scholar 

Bytyçi I, Penson PE, Mikhailidis DP, Wong ND, Hernandez AV, Sahebkar A, et al. Prevalence of statin intolerance: a meta-analysis. Eur Heart J. 2022;43(34):3213–23.

Article  PubMed  PubMed Central  Google Scholar 

Algharably EA, Filler I, Rosenfeld S, Grabowski K, Kreutz R. Statin intolerance - a question of definition. Expert Opin Drug Saf. 2017;16(1):55–63.

Article  CAS  PubMed  Google Scholar 

Scott D, Blizzard L, Fell J, Jones G. Statin therapy, muscle function and falls risk in community-dwelling older adults. QJM. 2009;102(9):625–33.

Article  CAS  PubMed  Google Scholar 

Riechman SE, Andrews RD, Maclean DA, Sheather S. Statins and dietary and serum cholesterol are associated with increased lean mass following resistance training. J Gerontol A Biol Sci Med Sci. 2007;62(10):1164–71.

Article  PubMed  Google Scholar 

Lin MH, Chiu SY, Chang PH, Lai YL, Chen PC, Ho WC. Hyperlipidemia and statins use for the risk of new diagnosed sarcopenia in patients with chronic kidney: a population-based study. Int J Environ Res Public Health. 2020. https://doi.org/10.3390/ijerph17051494.

Article  PubMed  PubMed Central  Google Scholar 

Huang ST, Otsuka R, Nishita Y, Meng LC, Hsiao FY, Shimokata H, et al. Risk of sarcopenia following long-term statin use in community-dwelling middle-aged and older adults in Japan. J Cachexia Sarcopenia Muscle. 2025;16(1):e13660.

Article  PubMed  Google Scholar 

Witham MD, Syddall HE, Dennison E, Cooper C, McMurdo ME, Sayer AA. ACE inhibitors, statins and thiazides: no association with change in grip strength among community dwelling older men and women from the Hertfordshire Cohort Study. Age Ageing. 2014;43(5):661–6.

Article  PubMed  Google Scholar 

Henderson RM, Lovato L, Miller ME, Fielding RA, Church TS, Newman AB, et al. Effect of statin use on mobility disability and its prevention in at-risk older adults: the LIFE study. J Gerontol A Biol Sci Med Sci. 2016;71(11):1519–24.

Article  PubMed  PubMed Central  Google Scholar 

Parker BA, Capizzi JA, Grimaldi AS, Clarkson PM, Cole SM, Keadle J, et al. Effect of statins on skeletal muscle function. Circ. 2013;127(1):96–103.

Article  CAS  Google Scholar 

Zeng W, Deng H, Luo Y, Zhong S, Huang M, Tomlinson B. Advances in statin adverse reactions and the potential mechanisms: a systematic review. J Adv Res. 2024. https://doi.org/10.1016/j.jare.2024.12.020.

Article  PubMed  PubMed Central  Google Scholar 

Spira D, Walston J, Buchmann N, Nikolov J, Demuth I, Steinhagen-Thiessen E, et al. Angiotensin-converting enzyme inhibitors and parameters of sarcopenia: relation to muscle mass, strength and function: data from the Berlin Aging Study-II (BASE-II). Drugs Aging. 2016;33(11):829–37.

Article  PubMed  Google Scholar 

Di Bari M, van de Poll-Franse LV, Onder G, Kritchevsky SB, Newman A, Harris TB, et al. Antihypertensive medications and differences in muscle mass in older persons: the health, aging and body composition study. J Am Geriatr Soc. 2004;52(6):961–6.

Article  PubMed  Google Scholar 

Kara M, Kara Ö, Ceran Y, Kaymak B, Kaya TC, Çıtır BN, et al. SARcopenia assessment in hypertension: the SARAH study. Am J Phys Med Rehabil. 2023;102(2):130–6.

Article  PubMed  Google Scholar 

Pozos-López T, Navarrete-Reyes AP, Ávila-Funes JA. Is frailty associated with cardiovascular drug use? J Am Geriatr Soc. 2011;59(10):1977–9.

Article  PubMed  Google Scholar 

Qaisar R, Kamli H, Karim A, Muhammad T, Ahmad F, Shaikh A. Angiotensin receptor blockers restore skeletal muscle in patients with chronic obstructive pulmonary disease. Arch Med Res. 2023;54(7):102890.

Article  CAS  PubMed  Google Scholar 

Pahor M, Anton SD, Beavers DP, Cauley JA, Fielding RA, Kritchevsky SB, et al. Effect of losartan and fish oil on plasma IL-6 and mobility in older persons. The ENRGISE pilot randomized clinical trial. J Gerontol A Biol Sci Med Sci. 2019;74(10):1612–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Caulfield L, Heslop P, Walesby KE, Sumukadas D, Sayer AA, Witham MD. Effect of angiotensin system inhibitors on physical performance in older people - a systematic review and meta-analysis. J Am Med Dir Assoc. 2021;22(6):1215-21.e2.

Article  PubMed  Google Scholar 

Takeshita H, Yamamoto K, Mogi M, Rakugi H. Muscle mass, muscle strength and the renin-angiotensin system. Clin Sci (Lond). 2024;138(24):1561–77.

Article  CAS  PubMed  Google Scholar 

Gale RP, Zhang MJ, Lazarus HM. The role of randomized controlled trials, registries, observational databases in evaluating new interventions. Best Pract Res Clin Haematol. 2023;36(4):101523.